Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2005
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662516A N, N-disubstituted diazocycloalkanes
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662257A Combination of PDE5 inhibitors with angiotensin II receptor antagonists
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662234A Use of thio-oxindole derivatives in treatment of hormone-related conditions
08/31/2005CN1662231A Prevention and treatment of functional somatic disorders, including stress-related disorders
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660435A New drug combinations
08/31/2005CN1660419A Adsorbent of compound urease for urea nitrogen and preparing method
08/31/2005CN1660404A Health product of preserving health, invigorating the kidney and supporting yang for male
08/31/2005CN1660391A Preparation of Chinese traditional medicine for treating prostatitis
08/31/2005CN1660372A Oral drop pill in use for clearing sway heat and toxic material, relieving inflammation and dysentery, and preparation method
08/31/2005CN1660360A Preparation from natural products for nourishing the liver and preparing method
08/31/2005CN1660349A Combination of medication by using beartyberry and dragon's blood resin as combination of activities
08/31/2005CN1660328A Medication for treating chronic prostatitis and preparation method
08/31/2005CN1660324A 'Guipu' capsule of clearing kidney for treating kidney disease
08/31/2005CN1660309A Adhibition agent of Chinese traditional medicine for treating prostatic hyperplasia and producing method
08/31/2005CN1660267A 'Yankening' pharmaceutical preparation and preparing method
08/31/2005CN1660242A Combination for restraining p38 subfanmily of protein kinase activated by mitogen and application
08/31/2005CN1660230A Nutritional oral liquid for health care and preparation method
08/31/2005CN1660225A Medication of effective part of bee pollen form cole, preparation method and application
08/31/2005CN1660194A Effervescence grains prepared by extracting epimedium, astragalus root etc. medicinal materials
08/31/2005CN1660177A Preparing oral taking medication in capsules by using milkvetch seed and extractive solely
08/31/2005CN1660171A Method for producing injection of houttuynia
08/31/2005CN1660170A Soft capsule of houttuynia and preparation method
08/31/2005CN1660153A Oral liquid for reviving nerve
08/31/2005CN1660129A Method for preparing agent of cyclodextrin-cellulose for adsorbing uric acid
08/31/2005CN1660118A Medication combination of containing finasteride and cyclodextrin or ramification
08/31/2005CN1660111A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660110A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660109A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660108A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1216873C Valsartan salts
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216855C Crystal polymorphism of aminoethylphenoxyacetic acid derivatives
08/31/2005CN1216636C Titanium slow-release composition
08/31/2005CN1216614C Medicinal composition for relaxing chronic renal failure
08/31/2005CN1216602C Combination of lipoic acids and conjugated acids for treating diabetic disorders
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936604 Treating hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis and water retention
08/30/2005CA2202879C Calcium receptor-active compounds
08/30/2005CA2136331C New pharmaceutical uses of krill enzymes
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077364A1 Transdermal solifenacin preparation and method of improving transdermal permeability thereof
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187275 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050186664 Albumin fusion proteins
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005CA2556404A1 Nitrogenous fused heteroaromatic ring derivative
08/25/2005CA2555789A1 Ctgf as target for the therapy of diabetic nephropathy
08/25/2005CA2554378A1 Bicycloamide derivative
08/24/2005EP1565474A2 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
08/24/2005EP1565467A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
08/24/2005EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use
08/24/2005EP1565174A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
08/24/2005EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1372624B1 Tramadol-based medicament
08/24/2005EP1360185B1 Carboline derivatives
08/24/2005EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1335917B1 Condensed pyridoindole derivatives
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
08/24/2005EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
08/24/2005EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways
08/24/2005CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens
08/24/2005CN1659180A Novel recombinant anticoagulant proteins
08/24/2005CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
08/24/2005CN1659162A Tricyclic thrombin receptor antagonists
08/24/2005CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same
08/24/2005CN1659155A 1-phenylalkyl-piperazines
08/24/2005CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659147A Pyridazine derivatives
08/24/2005CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1658886A Hormone replacement therapy
08/24/2005CN1658885A Hormone replacement therapy
08/24/2005CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 562